Related references
Note: Only part of the references are listed.Roles of Membrane and Vesicular Traffic in Regulation of the Hippo Pathway
Shilpi Verghese et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Arrestin domain-containing 3 (Arrdc3) modulates insulin action and glucose metabolism in liver
Thiago M. Batista et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy
Victoria Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Arrestin Domain Containing 3 Reverses Epithelial to Mesenchymal Transition and Chemo-Resistance of TNBC Cells by Up-Regulating Expression of miR-200b
Young Hwa Soung et al.
CELLS (2019)
MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types
J. Randall McAuley et al.
ONCOGENE (2019)
The Hippo Pathway: Biology and Pathophysiology
Shenghong Ma et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 88 (2019)
ARRDC3 suppresses colorectal cancer progression through destabilizing the oncoprotein YAP
Xu Shen et al.
FEBS LETTERS (2018)
GPCRs in Cancer: Protease-Activated Receptors, Endocytic Adaptors and Signaling
Aleena K. S. Arakaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The α-arrestin ARRDC3 suppresses breast carcinoma invasion by regulating G protein-coupled receptor lysosomal sorting and signaling
Aleena K. S. Arakaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell
Steven W. Plouffe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets
Paul A. Insel et al.
FRONTIERS IN PHARMACOLOGY (2018)
Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction
Jeetendra Kumar Nag et al.
CANCER AND METASTASIS REVIEWS (2018)
Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
Brian Bierie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2-early breast cancer
Gyungyub Gong et al.
SCIENTIFIC REPORTS (2017)
Mechanisms of Hippo pathway regulation
Zhipeng Meng et al.
GENES & DEVELOPMENT (2016)
Destabilization of Lysophosphatidic Acid Receptor 1 Reduces Cytokine Release and Protects Against Lung Injury
Jing Zhao et al.
EBIOMEDICINE (2016)
ALIX Regulates the Ubiquitin-Independent Lysosomal Sorting of the P2Y1 Purinergic Receptor via a YPX3L Motif
Michael R. Dores et al.
PLOS ONE (2016)
Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer
Juan Diaz-Martin et al.
ENDOCRINE-RELATED CANCER (2015)
Estrogen regulates Hippo signaling via GPER in breast cancer
Xin Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The α-arrestin ARRDC3 mediates ALIX ubiquitination and G protein-coupled receptor lysosomal sorting
Michael R. Dores et al.
MOLECULAR BIOLOGY OF THE CELL (2015)
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
M. Bartucci et al.
ONCOGENE (2015)
Structural and Biochemical Basis for Ubiquitin Ligase Recruitment by Arrestin-related Domain-containing Protein-3 ( ARRDC3)*
Shiqian Qi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
THE BIOLOGY OF YAP/TAZ: HIPPO SIGNALING AND BEYOND
Stefano Piccolo et al.
PHYSIOLOGICAL REVIEWS (2014)
Epigenetic silencing of ARRDC3 expression in basal-like breast cancer cells
Young Hwa Soung et al.
SCIENTIFIC REPORTS (2014)
The Hippo Signaling Pathway Interactome
Young Kwon et al.
SCIENCE (2013)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs)
Jung-Soon Mo et al.
GENES & DEVELOPMENT (2012)
ALIX binds a YPX3L motif of the GPCR PAR1 and mediates ubiquitin-independent ESCRT-III/MVB sorting
Michael R. Dores et al.
JOURNAL OF CELL BIOLOGY (2012)
Proteomic Analyses Reveal Divergent Ubiquitylation Site Patterns in Murine Tissues
Sebastian A. Wagner et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
John M. Lamar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
Multiple Interactions between the ESCRT Machinery and Arrestin-Related Proteins: Implications for PPXY-Dependent Budding
Susanne Rauch et al.
JOURNAL OF VIROLOGY (2011)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
ARRDC3 suppresses breast cancer progression by negatively regulating integrin β4
K. M. Draheim et al.
ONCOGENE (2010)
A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells
Siew Wee Chan et al.
CANCER RESEARCH (2008)
Modulating tone: the overture of S1P receptor immunotherapeutics
Hugh Rosen et al.
IMMUNOLOGICAL REVIEWS (2008)
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway
Qun-Ying Lei et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion
P. Arora et al.
ONCOGENE (2008)
Integrated profiling of basal and luminal breast cancers
Jose Adelaide et al.
CANCER RESEARCH (2007)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) mediates post-endocytic trafficking of protease-activated receptor 2 and calcitonin receptor-like receptor
Burcu Hasdemir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion
MA Booden et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Share Paper
